89R13100 AB-D
By: Hancock S.B. No. 2378
A BILL TO BE ENTITLED
AN ACT
relating to a report on governmental opioid antagonist programs to
reverse and prevent opioid overdoses.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subchapter B, Chapter 461A, Health and Safety
Code, is amended by adding Section 461A.060 to read as follows:
Sec. 461A.060. BIENNIAL REPORT ON OPIOID ANTAGONIST
PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION. (a) In this
section, "opioid antagonist" has the meaning assigned by Section
483.101.
(b) Not later than October 1 of each even-numbered year, the
commission shall:
(1) prepare a report evaluating the distribution of
opioid antagonists in this state to reverse and prevent opioid
overdoses; and
(2) submit the report to the governor, the lieutenant
governor, and the speaker of the house of representatives.
(c) The report described by Subsection (b) must:
(1) include a needs assessment for the opioid
antagonist programs established by state agencies and institutions
of higher education;
(2) establish a statewide saturation goal for opioid
antagonists and include:
(A) a description of the data sources and
methodology used to estimate insufficiencies in the current supply
of opioid antagonists; and
(B) a communications plan to address opioid
overdoses in areas of this state at higher risk for increased
numbers of overdoses;
(3) include a description of all state and federal
money appropriated to governmental opioid antagonist programs;
(4) establish opioid antagonist distribution
strategies for this state;
(5) list and describe all available state and
federally funded purchase and distribution programs for opioid
antagonists; and
(6) recommend improvements for addressing opioid
overdoses among high-risk populations, including school-aged
children, pregnant and postpartum women, and individuals residing
in rural areas of this state.
(d) In preparing the report under this section, the
commission shall coordinate and consult with each state agency and
institution of higher education that receives funding or other
resources for the distribution of opioid antagonists.
SECTION 2. This Act takes effect September 1, 2025.